1. Everolimus in combination with Imatinib overcomes resistance in Chronic myeloid leukaemia

   • Raquel Alves
   • Ana Cristina Gonçalves
   • Ana B. Sarmento-Ribeiro

   Original Paper 22 February 2019 Article: 30

   

2. Best treatment options for advanced renal cell carcinoma (RCC) patients: a Delphi consensus study

   • José Luis Pérez-Gracia
   • Daniel Castellano
   • Cristina Suárez

   Original Paper 19 February 2019 Article: 29

3. Factors that impact the outcomes in testicular germ cell tumors in low–middle-income countries

   • S. V. Saju
   • Venkatraman Radhakrishnan
   • Tenali Gnana Sagar

   Original Paper 06 February 2019 Article: 28

   

4. Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements—a clinicopathologic and genomic sequencing-based discussion

   • Steven C. Weindorf
   • Alexander S. Taylor
   • Rohit Mehra

   Short Communication 02 February 2019 Article: 27

   

5. Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma

   • Omar Abdel-Rahman
   • Winson Y. Cheung

   Original Paper 01 February 2019 Article: 26

   

6. The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes treated with azacitidine

   • Takahiro Kamiya
   • Tomonori Nakazato

   Letter to the Editor 31 January 2019 Article: 25

   

7. Real-world outcomes in patients with unresected stage III non-small cell lung cancer

   • Kellie J. Ryan
   • Karen E. Skinner
   • Noam A. VanderWalde

   Original Paper Open access 31 January 2019 Article: 24

   

8. Deficiency of mismatch repair genes is less frequently observed in signet ring cell compared with non-signet ring cell gastric cancer

   • Yosuke Hirotsu
   • Hitoshi Mochizuki
   • Masao Omata

   Original Paper 29 January 2019 Article: 23